Role of polymorphic XRCC6 (Ku70)/XRCC7 (DNA-PKcs) genes towards susceptibility and prognosis of lung cancer patients undergoing platinum based doublet chemotherapy.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- February 3, 2018
published in
- Molecular biology reports Journal
has subject area
- Antineoplastic Combined Chemotherapy Protocols
- Carboplatin
- Case-Control Studies
- Cisplatin
- DNA Breaks, Double-Stranded
- DNA, Neoplasm
- DNA-Activated Protein Kinase
- Docetaxel
- Female
- Genetic Predisposition to Disease
- Humans
- Kaplan-Meier Estimate
- Ku Autoantigen
- Lung Neoplasms
- Male
- Middle Aged
- Nuclear Proteins
- Pemetrexed
- Polymorphism, Single Nucleotide
- Prognosis
- Risk Factors
- Small Cell Lung Carcinoma
- Taxoids